Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Comparison of Rivaroxaban and Low Molecular Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism

Craig I. Coleman, Kimberly Snow Caroti, Khaled Abdelgawwad, George Psaroudakis, Marcela Rivera, Gunnar Brobert, Alexander T. Cohen, Alok A. Khorana, Cecilia Becattini, Agnes Y. Lee, Anders Ekbom, Marc Carrier

Blood (2022) 140 (Supplement 1): 11368–11369.

https://doi.org/10.1182/blood-2022-166949

Published: 2022

Journal Articles

Rivaroxaban Versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism: A Head-to-Head Analysis of the United States Cohort of the Observational Study in Cancer-Associated Thrombosis for Rivaroxaban: (H2H-OSCAR-US)

Kimberly Snow Caroti, Khaled Abdelgawwad, George Psaroudakis, Marcela Rivera, Gunnar Brobert, Alexander T Cohen, Alok A Khorana, Cecilia Becattini, Agnes Y. Lee, Anders Ekbom, Marc Carrier, Craig I. Coleman

Blood (2022) 140 (Supplement 1): 1257–1258.

https://doi.org/10.1182/blood-2022-167801

Published: 2022

Journal Articles

Efficacy and Safety of Tinzaparin in CAT Patients with Hematological Malignancy

Agnes Y. Lee, Pieter W. Kamphuisen, Rupert Bauersachs, Nicolas Janus, Randall Leeder, Henrick Thoning, Alok A Khorana

Blood (2021) 138 (Supplement 1): 4273.

https://doi.org/10.1182/blood-2021-145886

Published: 2021

Journal Articles

Efficacy and Safety of Tinzaparin in CAT Patients with Metastatic Disease

Agnes Y. Lee, MD MSc, Pieter W. Kamphuisen, MD PhD, Rupert Bauersachs, MD PhD, Karen Turpin, BScN, MSc, Jes Birger Hansen, Alok A Khorana, MD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-136039

Published: 2020

Journal Articles

Reasons for Failure to Remove Inferior Vena Cava Filters: Retrospective Study in a Tertiary Care and Trauma Centre

Erica A. Peterson, MD, Paul R. Yenson, MD, BSc, FRCPC, Dave Liu, MD, FRCPC, Andy W.J. Lee, Agnes Y. Lee, MD, MSc, FRCPC

Blood (2011) 118 (21): 3141.

https://doi.org/10.1182/blood.V118.21.3141.3141

Published: 2011

Journal Articles

Thromboprophylaxis In Multiple Myeloma Patients Undergoing Immunomodulatory Therapy with Thalidomide and Lenalidomide: A Systematic Review and Meta-Analysis.

Marc Carrier, MD, MSc, Gregoire Le Gal, MD, PhD, Jason Tay, MD, Cynthia M. Wu, MD, FRCPC, Agnes Y. Lee, MD, MSc

Blood (2010) 116 (21): 1090.

https://doi.org/10.1182/blood.V116.21.1090.1090

Published: 2010

Journal Articles

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Martha L Louzada, BSc, MD, Marc Carrier, MD, MSc, Alejandro Lazo-Langner, MD, MSC, Vi Dao, MD, Jerry Zhang, MD, Michael J. Kovacs, MD, FRCPC, Agnes Y. Lee, MD, MSc, Mark N. Levine, MD, MSC, Guy Meyer, MD, Marc Rodger, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 4209.

https://doi.org/10.1182/blood.V116.21.4209.4209

Published: 2010

Journal Articles

Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies

Wael Saber, MD, MS, Teng Moua, MD, Eliot C. Williams, MD, PhD, Melina Verso, MD, Giancarlo Agnelli, MD, Stephen Couban, MD, Annie Young, RN, Marcello De Cicco, MD, Roberto Biffi, MD, Cornelis J. van Rooden, MD, Menno V. Huisman, MD, PhD, Daniele Fagnani, MD, Claudio Cimminiello, MD, Marco Moia, MD, Stephen P. Povoski, MD, Sharp Malak, MD, MPH, Agnes Y. Lee, MD, MSc, FRCPC

Blood (2008) 112 (11): 3814.

https://doi.org/10.1182/blood.V112.11.3814.3814

Published: 2008

Journal Articles

Prospective Cohort Study of the Incidence, Risk Factors and Long-Term Sequelae of Symptomatic Catheter-Related Thrombosis in Adults with Cancer.

Agnes Y. Lee, MD, Carolyn Webb, RN, Qing Guo, MMath, Lorrie Costantini, BSc, Greg Butler, MD, Mark N. Levine, MD

Blood (2004) 104 (11): 2200.

https://doi.org/10.1182/blood.V104.11.2200.2200

Published: 2004

NARROW

Comparison of Rivaroxaban and Low Molecular Weight Heparin in the Treatment of Cancer-Associated Venous Thromboembolism

Rivaroxaban Versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism: A Head-to-Head Analysis of the United States Cohort of the Observational Study in Cancer-Associated Thrombosis for Rivaroxaban: (H2H-OSCAR-US)

Efficacy and Safety of Tinzaparin in CAT Patients with Hematological Malignancy

Efficacy and Safety of Tinzaparin in CAT Patients with Metastatic Disease

Reasons for Failure to Remove Inferior Vena Cava Filters: Retrospective Study in a Tertiary Care and Trauma Centre

Thromboprophylaxis In Multiple Myeloma Patients Undergoing Immunomodulatory Therapy with Thalidomide and Lenalidomide: A Systematic Review and Meta-Analysis.

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies

Prospective Cohort Study of the Incidence, Risk Factors and Long-Term Sequelae of Symptomatic Catheter-Related Thrombosis in Adults with Cancer.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only